Dahlgren Lars
SEC CIK 1960646 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PM | Philip Morris International | Pres. Smoke-Free Oral Products | 26.8K | — | $562.7K | 6 | 2023-02-09 | 2025-03-06 |
Most active insiders at PM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Olczak Jacek | Group CEO PMI, Dir | — | $14.57M |
| 2 | Babeau Emmanuel | Group CFO | — | $6.14M |
| 3 | De Wilde Frederic | CEO PMI International | — | $3.65M |
| 4 | Kennedy Stacey | CEO PMI U.S | — | $2.63M |
| 5 | Dobrowolski Reginaldo | Group Ctrl | — | $1.10M |
| 6 | Guerin Yann | Group CLO | — | $726.8K |
| 7 | Bough Bonin | Dir | — | — |
| 8 | Combes Michel | Dir | — | — |
| 9 | Yanai Shlomo | Dir | — | — |
| 10 | Morparia Kalpana | Dir | — | — |
Dahlgren Lars made no open-market trades at PM in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-07 | 2025-03-06 | PM | Philip Morris International | Dahlgren Lars | Pres. Smoke-Free Oral Products | S - Sale | $152.96 | -3,679 | 26.8K | -12% | -$562.7K | |
| 2025-02-21 | 2025-02-19 | PM | Philip Morris International | Dahlgren Lars | Pres. Smoke-Free Oral Products | F - Tax | $149.80 | -6,925 | 30.5K | -19% | -$1.04M | |
| 2025-02-07 | 2025-02-05 | PM | Philip Morris International | Dahlgren Lars | Pres. Smoke-Free Oral Products | A - Grant | $0.00 | +8,653 | 37.4K | +30% | $0 | |
| 2024-02-23 | 2024-02-21 | PM | Philip Morris International | Dahlgren Lars | Pres. Smoke-Free Oral Products | F - Tax | $90.57 | -4,881 | 28.8K | -15% | -$442.1K | |
| M | 2024-02-09 | 2024-02-07+ | PM | Philip Morris International | Dahlgren Lars | Pres. Smoke-Free Oral Products | A - Grant | $43.92 | +11.0K | 28.4K | +63% | +$483.2K |
| 2023-02-10 | 2023-02-09 | PM | Philip Morris International | Dahlgren Lars | Pres. Smoke-Free Oral Products | A - Grant | $102.38 | +4,150 | 22.7K | +22% | +$424.9K |
Purchase Sale Sale after option exercise All abbreviations